Access to PrEP for Black communities

That this House is concerned that there is inequitable access for all who need access to the HIV prevention pill pre-exposure prophylaxis (PrEP); notes that PrEP is highly effective at stopping HIV and extremely cost-effective when compared with a lifetime of HIV treatment; further notes that in the UK, Black African men and women are the second-largest group affected by HIV; recognises that there was disappointingly low coverage of access to PrEP on the Impact trial for women and Black communities; is aware that the routine commissioning of PrEP has focused on providing access to individuals previously on the Impact trial; calls on local commissioners and councils to provide equitable access to all high-risk individuals who need access to PrEP; further calls on the Government to increase funding for PrEP in 2021; and urges local public health teams to improve knowledge about PrEP among Black communities.